SPECIAL NOTICE
A -- Notice of Contract Award - Orexo US, Inc.
- Notice Date
- 9/26/2025 10:05:51 AM
- Notice Type
- Special Notice
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- BARDA - ASPR / DAAPPO / BARDA DCMA WASHINGTON DC 20515 USA
- ZIP Code
- 20515
- Solicitation Number
- BARDA-BAA-OrexoNotice
- Response Due
- 9/24/2025 2:00:00 PM
- Archive Date
- 10/09/2025
- Point of Contact
- Jonathan Gonzalez, Contracting Officer, Phone: 2023817248, Joann Kambaja, Contract Specialist, Phone: 202-913-5470
- E-Mail Address
-
Jonathan.Gonzalez@hhs.gov, Joann.Kambaja@hhs.gov
(Jonathan.Gonzalez@hhs.gov, Joann.Kambaja@hhs.gov)
- Small Business Set-Aside
- NONE No Set aside used
- Description
- Award Notice for Orexo US, Inc. (Contract 75A50125C00010). Clinical development of OX390 (atipamezole) as an ?2 agonist reversal agent for human use to counteract the sedative effects of xylazine, medetomidine, and other ?2 agonists that are increasingly found in combination with IMF.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/workspace/contract/opp/2f2165fde1f3420891121bb88d554782/view)
- Place of Performance
- Address: Morristown, NJ 07960, USA
- Zip Code: 07960
- Country: USA
- Zip Code: 07960
- Record
- SN07605876-F 20250928/250926230043 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |